Go Pro
→ Ready to give options a try? Your first trade (Ticker included) -INSIDE (From Base Camp Trading) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biogen Inc. stock logo
BIIB
Biogen
$207.94
+0.8%		$202.33
$127.00
▼
$219.72
$30.72B0.171.37 million shs840,506 shs
Netflix, Inc. stock logo
NFLX
Netflix
$74.14
+0.6%		$75.32
$65.08
▼
$126.71
$308.71B1.5248.35 million shs24.78 million shs
NIKE, Inc. stock logo
NKE
NIKE
$41.67
-0.8%		$43.18
$40.00
▼
$80.17
$61.86B1.1118.40 million shs21.99 million shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biogen Inc. stock logo
BIIB
Biogen
0.00%+2.46%+4.54%+7.49%+60.77%
Netflix, Inc. stock logo
NFLX
Netflix
0.00%+3.39%-1.76%-15.22%-37.09%
NIKE, Inc. stock logo
NKE
NIKE
0.00%-0.47%-2.53%-5.52%-44.82%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biogen Inc. stock logo
BIIB
Biogen
$207.94
+0.8%		$202.33
$127.00
▼
$219.72
$30.72B0.171.37 million shs840,506 shs
Netflix, Inc. stock logo
NFLX
Netflix
$74.14
+0.6%		$75.32
$65.08
▼
$126.71
$308.71B1.5248.35 million shs24.78 million shs
NIKE, Inc. stock logo
NKE
NIKE
$41.67
-0.8%		$43.18
$40.00
▼
$80.17
$61.86B1.1118.40 million shs21.99 million shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biogen Inc. stock logo
BIIB
Biogen
0.00%+2.46%+4.54%+7.49%+60.77%
Netflix, Inc. stock logo
NFLX
Netflix
0.00%+3.39%-1.76%-15.22%-37.09%
NIKE, Inc. stock logo
NKE
NIKE
0.00%-0.47%-2.53%-5.52%-44.82%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Biogen Inc. stock logo
BIIB
Biogen
2.56
Moderate Buy$224.618.02% Upside
Netflix, Inc. stock logo
NFLX
Netflix
2.73
Moderate Buy$103.4839.58% Upside
NIKE, Inc. stock logo
NKE
NIKE
2.27
Hold$53.5328.48% Upside

Current Analyst Ratings Breakdown

Latest BIIB, NKE, and NFLX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/4/2026
Biogen Inc. stock logo
BIIB
Biogen
Mizuho logo
Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$221.00 ➝ $241.00
8/4/2026
NIKE, Inc. stock logo
NKE
NIKE
JPMorgan Chase & Co. logo
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral ➝ Underweight$47.00 ➝ $40.00
8/3/2026
Biogen Inc. stock logo
BIIB
Biogen
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$200.00 ➝ $215.00
7/30/2026
Biogen Inc. stock logo
BIIB
Biogen
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$237.00 ➝ $251.00
7/30/2026
Biogen Inc. stock logo
BIIB
Biogen
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOutperform$242.00 ➝ $240.00
7/30/2026
Biogen Inc. stock logo
BIIB
Biogen
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$225.00 ➝ $240.00
7/30/2026
Biogen Inc. stock logo
BIIB
Biogen
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$245.00 ➝ $248.00
7/30/2026
Biogen Inc. stock logo
BIIB
Biogen
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$222.00 ➝ $231.00
7/30/2026
Biogen Inc. stock logo
BIIB
Biogen
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$215.00 ➝ $225.00
7/30/2026
Biogen Inc. stock logo
BIIB
Biogen
Wedbush logo
Wedbush
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$201.00 ➝ $215.00
7/29/2026
Biogen Inc. stock logo
BIIB
Biogen
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C)
(Data available from 8/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Biogen Inc. stock logo
BIIB
Biogen
$9.89B3.11$22.63 per share9.19$127.56 per share1.63
Netflix, Inc. stock logo
NFLX
Netflix
$45.18B6.83$6.57 per share11.29$7.24 per share10.24
NIKE, Inc. stock logo
NKE
NIKE
$46.40B1.33$2.11 per share19.73$10.02 per share4.16
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Biogen Inc. stock logo
BIIB
Biogen
$1.29B$5.6536.8012.696.428.32%11.18%6.88%N/A
Netflix, Inc. stock logo
NFLX
Netflix
$10.98B$3.1823.3419.360.9328.22%40.02%19.81%10/20/2026 (Estimated)
NIKE, Inc. stock logo
NKE
NIKE
$3.11B$2.0919.9417.811.856.70%16.54%6.21%9/29/2026 (Estimated)

Latest BIIB, NKE, and NFLX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/29/2026Q2 2026
Biogen Inc. stock logo
BIIB
Biogen
$2.94$3.60+$0.66$0.66$2.46 billion$2.74 billion
7/16/2026Q2 2026
Netflix, Inc. stock logo
NFLX
Netflix
$0.79$0.80+$0.01$0.80$12.58 billion$12.56 billion
6/30/2026Q4 2026
NIKE, Inc. stock logo
NKE
NIKE
$0.11$0.20+$0.09$0.72$10.85 billion$10.97 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Biogen Inc. stock logo
BIIB
Biogen
N/AN/AN/AN/AN/A
Netflix, Inc. stock logo
NFLX
Netflix
N/AN/AN/AN/AN/A
NIKE, Inc. stock logo
NKE
NIKE
$1.643.94%+8.65%78.47%22 Years

Latest BIIB, NKE, and NFLX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/6/2026
NIKE, Inc. stock logo
NKE
NIKE
quarterly$0.413.91%9/1/20269/1/202610/1/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Biogen Inc. stock logo
BIIB
Biogen
0.39
1.87
1.26
Netflix, Inc. stock logo
NFLX
Netflix
0.39
1.14
1.14
NIKE, Inc. stock logo
NKE
NIKE
0.40
1.96
1.36

Institutional Ownership

CompanyInstitutional Ownership
Biogen Inc. stock logo
BIIB
Biogen
87.93%
Netflix, Inc. stock logo
NFLX
Netflix
80.93%
NIKE, Inc. stock logo
NKE
NIKE
64.25%

Insider Ownership

CompanyInsider Ownership
Biogen Inc. stock logo
BIIB
Biogen
0.25%
Netflix, Inc. stock logo
NFLX
Netflix
1.24%
NIKE, Inc. stock logo
NKE
NIKE
1.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Biogen Inc. stock logo
BIIB
Biogen
7,500147.75 million147.39 millionOptionable
Netflix, Inc. stock logo
NFLX
Netflix
16,0004.16 billion4.11 billionOptionable
NIKE, Inc. stock logo
NKE
NIKE
73,0001.48 billion1.47 billionOptionable

Recent News About These Companies

NIKE, Inc. $NKE Shares Sold by Jacobs & Co. CA
 |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-nike-inc-nke-shares-sold-by-jacobs-co-ca-2026-08-09/
Top Luxury Goods Stocks To Follow Today - August 8th
August 8 at 3:02 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/top-luxury-goods-stocks-to-follow-today-august-8th-2026-08-08/
Nike (NKE) Is Betting Big on Basketball’s Next Generation. Will It Pay Off?
August 8 at 11:40 AM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/nike-nke-betting-big-basketball-132534474.html
Nike (NKE) Is Betting Big on Basketball’s Next Generation. Will It Pay Off? 
August 8 at 10:51 AM  |  insidermonkey.comhttps://www.insidermonkey.com/blog/nike-nke-is-betting-big-on-basketballs-next-generation-will-it-pay-off-1808121/
NIKE (NYSE:NKE) EVP Philip Mccartney Sells 524 Shares of Stock
August 8 at 7:36 AM  |  insidertrades.comhttps://www.insidertrades.com/alerts/nyse-nke-insider-buying-and-selling-2026-08-08/
NIKE, Inc. $NKE Stock Holdings Boosted by Rockland Trust Co.
August 8 at 6:16 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-nike-inc-nke-stock-holdings-boosted-by-rockland-trust-co-2026-08-08/
NIKE, Inc. $NKE Shares Purchased by Assenagon Asset Management S.A.
August 8 at 3:14 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-nike-inc-nke-shares-purchased-by-assenagon-asset-management-sa-2026-08-08/
NIKE (NYSE:NKE) Strategy Reset Puts Product Growth In Focus
August 7 at 5:44 PM  |  kalkinemedia.comK
Inside Nike (NYSE:NKE)'s Uneven Path Between Running Strength and Sportswear Weakness
August 7 at 5:44 PM  |  kalkinemedia.comK
Philip Mccartney Sells 524 Shares of NIKE (NYSE:NKE) Stock
August 7 at 5:21 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/philip-mccartney-sells-524-shares-of-nike-nysenke-stock-2026-08-07/
Venkatesh Alagirisamy Sells 890 Shares of NIKE (NYSE:NKE) Stock
August 7 at 5:21 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/venkatesh-alagirisamy-sells-890-shares-of-nike-nysenke-stock-2026-08-07/
Matthew Friend Sells 2,463 Shares of NIKE (NYSE:NKE) Stock
August 7 at 5:21 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/matthew-friend-sells-2463-shares-of-nike-nysenke-stock-2026-08-07/
Best Luxury Goods Stocks To Add to Your Watchlist - August 7th
August 7 at 3:03 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/best-luxury-goods-stocks-to-add-to-your-watchlist-august-7th-2026-08-07/
NIKE, Inc. (NYSE:NKE) Declares $0.41 Quarterly Dividend
August 7 at 8:49 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/nike-inc-nysenke-declares-041-quarterly-dividend-2026-08-07/
Pacer Advisors Inc. Sells 33,772 Shares of NIKE, Inc. $NKE
August 7 at 5:19 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-pacer-advisors-inc-sells-33772-shares-of-nike-inc-nke-2026-08-07/
NIKE, Inc. (NYSE:NKE) Receives Consensus Recommendation of "Hold" from Brokerages
August 7 at 2:28 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30945659
NIKE, Inc. (NYSE:NKE) Receives Average Rating of "Hold" from Brokerages
August 7 at 2:28 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/nike-inc-nysenke-receives-average-rating-of-hold-from-brokerages-2026-08-07/
NIKE, Inc. Declares $0.41 Quarterly Dividend
August 6 at 8:21 PM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/nike-inc-declares-0-41-210000675.html
Luxury Goods Stocks To Follow Today - August 6th
August 6 at 3:03 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/luxury-goods-stocks-to-follow-today-august-6th-2026-08-06/
Promising Apparel Stocks To Watch Now - August 6th
August 6 at 12:02 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/promising-apparel-stocks-to-watch-now-august-6th-2026-08-06/
JPMorgan cuts Nike stock to sell on longer turnaround
August 6 at 9:35 AM  |  msn.comhttps://www.msn.com/en-us/money/topstocks/jpmorgan-cuts-nike-stock-to-sell-on-longer-turnaround/ar-AA29u3u1

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Two Very Large Crude Carriers (VLLCs) sailing side by side on open ocean waters, viewed from above.
Strait of Hormuz Tensions Spike Tanker Trade: These 2 Stocks Are Set to Benefit
By Dan Schmidt | July 19, 2026
Voltmax electrical equipment and cable spools at an industrial construction site with a steel-framed building under construction.
3 Non-Tech Stocks Still Winning Big on AI
By Nathan Reiff | July 13, 2026
Netflix logo projected in a dim living room with a remote and Netflix mug on the coffee table.
Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop
By Chris Markoch | July 18, 2026
Green upward arrow between two coin stacks on a desk, with a computer monitor showing financial charts in the background.
A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
By Nathan Reiff | July 22, 2026
Illustration of a computer chip on a circuit board with server racks and a stock price chart overlay.
Insiders Sell, Institutions Buy: The AI Trade Is Getting More Interesting
By Thomas Hughes | July 29, 2026
Biogen stock logo

Biogen NASDAQ:BIIB

$207.94 +1.66 (+0.80%)
Closing price 08/7/2026 04:00 PM Eastern
Extended Trading
$207.60 -0.34 (-0.16%)
As of 08/7/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; ADUHELM to treat Alzheimer's disease; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; FLIXABI, an infliximab biosimilar referencing REMICADE; and BYOOVIZ, a ranibizumab biosimilar referencing LUCENTIS. It offers RITUXAN for treating non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; OCREVUS for relapsing MS and primary progressive MS; LUNSUMIO to treat relapsed or refractory follicular lymphoma; glofitamab for non-Hodgkin's lymphoma; and other anti-CD20 therapies. In addition, the company is developing various products for the treatment of MS, Alzheimer's disease and dementia, neuromuscular disorders, Parkinson's disease and movement disorders, neuropsychiatry, genetic neurodevelopmental disorders, and biosimilars, which are under various stages of development. It has collaboration and license agreements with Acorda Therapeutics, Inc.; Alkermes Pharma Ireland Limited; Denali Therapeutics Inc.; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; Ionis Pharmaceuticals, Inc.; Samsung Bioepis Co., Ltd.; Sangamo Therapeutics, Inc.; and Sage Therapeutics, Inc., as well as collaboration with Fujirebio to potentially identify and develop blood-based biomarkers for tau pathology in the brain. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.

Netflix stock logo

Netflix NASDAQ:NFLX

$74.14 +0.45 (+0.61%)
Closing price 08/7/2026 04:00 PM Eastern
Extended Trading
$74.17 +0.03 (+0.04%)
As of 08/7/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Netflix, Inc. provides entertainment services. It offers TV series, documentaries, feature films, and games across various genres and languages. The company also provides members the ability to receive streaming content through a host of internet-connected devices, including TVs, digital video players, TV set-top boxes, and mobile devices. It has operations in approximately 190 countries. The company was incorporated in 1997 and is headquartered in Los Gatos, California.

NIKE stock logo

NIKE NYSE:NKE

$41.66 -0.34 (-0.80%)
Closing price 08/7/2026 03:59 PM Eastern
Extended Trading
$41.74 +0.08 (+0.19%)
As of 08/7/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

NIKE, Inc., together with its subsidiaries, designs, develops, markets, and sells athletic footwear, apparel, equipment, accessories, and services worldwide. The company provides athletic and casual footwear, apparel, and accessories under the Jumpman trademark; and casual sneakers, apparel, and accessories under the Converse, Chuck Taylor, All Star, One Star, Star Chevron, and Jack Purcell trademarks. It also sells a line of performance equipment and accessories comprising bags, sport balls, socks, eyewear, timepieces, digital devices, bats, gloves, protective equipment, and other equipment for sports activities under the NIKE brand; and various plastic products to other manufacturers. In addition, the company markets apparel with licensed college and professional team, and league logos, as well as sells sports apparel; and licenses unaffiliated parties to manufacture and sell apparel, digital devices, and applications and other equipment for sports activities under NIKE-owned trademarks. It sells its products to footwear stores; sporting goods stores; athletic specialty stores; department stores; skate, tennis, and golf shops; and other retail accounts through NIKE-owned retail stores, digital platforms, independent distributors, licensees, and sales representatives. NIKE, Inc. was founded in 1964 and is headquartered in Beaverton, Oregon.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas